AcuCort AB Company Description

AcuCort AB (publ) operates as a pharmaceutical company.

It offers Zeqmelit, an oral film containing the glucocorticoid dexamethasone for the treatment of acute allergic reactions, croup in children, nausea and vomiting associated with chemotherapy, and for the treatment of patients with COVID-19 who experience respiratory difficulties and require oxygen therapy.

The company was incorporated in 2006 and is based in Lund, Sweden.